| Product Code: ETC10707054 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland`s ophthalmic drugs and devices import market continued to see steady contributions from top exporting countries such as the UK, Belgium, Japan, USA, and Switzerland. Despite a moderate concentration level in the market, the compound annual growth rate (CAGR) from 2020 to 2024 was -6.61%. However, there was a notable improvement in the growth rate from 2023 to 2024, which stood at 6.86%. This indicates a potential shift towards positive growth trends in the Irish ophthalmic import market, potentially driven by innovative products and market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Ophthalmic Drugs Devices Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Ophthalmic Drugs Devices Market - Industry Life Cycle |
3.4 Ireland Ophthalmic Drugs Devices Market - Porter's Five Forces |
3.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Ireland Ophthalmic Drugs Devices Market Revenues & Volume Share, By Delivery Method, 2022 & 2032F |
3.7 Ireland Ophthalmic Drugs Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Ireland Ophthalmic Drugs Devices Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Ireland Ophthalmic Drugs Devices Market Revenues & Volume Share, By Formulation, 2022 & 2032F |
4 Ireland Ophthalmic Drugs Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye disorders in Ireland |
4.2.2 Rising demand for innovative ophthalmic drugs and devices |
4.2.3 Technological advancements in the ophthalmic sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of ophthalmic drugs and devices |
4.3.2 High cost associated with advanced ophthalmic treatments |
4.3.3 Limited access to specialized eye care services in remote areas of Ireland |
5 Ireland Ophthalmic Drugs Devices Market Trends |
6 Ireland Ophthalmic Drugs Devices Market, By Types |
6.1 Ireland Ophthalmic Drugs Devices Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.1.4 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Oral, 2022 - 2032F |
6.1.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Ointments, 2022 - 2032F |
6.1.6 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Eye Drops, 2022 - 2032F |
6.2 Ireland Ophthalmic Drugs Devices Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Topical, 2022 - 2032F |
6.2.3 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Implantable, 2022 - 2032F |
6.2.4 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Nasal Spray, 2022 - 2032F |
6.2.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Ophthalmic Patches, 2022 - 2032F |
6.3 Ireland Ophthalmic Drugs Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Devices, 2022 - 2032F |
6.3.3 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Surgical Instruments, 2022 - 2032F |
6.3.4 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Vision Correction, 2022 - 2032F |
6.3.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Imaging, 2022 - 2032F |
6.4 Ireland Ophthalmic Drugs Devices Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Glaucoma, 2022 - 2032F |
6.4.3 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Cataract, 2022 - 2032F |
6.4.4 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Dry Eye, 2022 - 2032F |
6.4.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Retinal Disorders, 2022 - 2032F |
6.5 Ireland Ophthalmic Drugs Devices Market, By Formulation |
6.5.1 Overview and Analysis |
6.5.2 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.5.3 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Gel, 2022 - 2032F |
6.5.4 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Cream, 2022 - 2032F |
6.5.5 Ireland Ophthalmic Drugs Devices Market Revenues & Volume, By Powder, 2022 - 2032F |
7 Ireland Ophthalmic Drugs Devices Market Import-Export Trade Statistics |
7.1 Ireland Ophthalmic Drugs Devices Market Export to Major Countries |
7.2 Ireland Ophthalmic Drugs Devices Market Imports from Major Countries |
8 Ireland Ophthalmic Drugs Devices Market Key Performance Indicators |
8.1 Number of clinical trials for new ophthalmic drugs and devices in Ireland |
8.2 Adoption rate of telemedicine for eye care consultations |
8.3 Percentage of healthcare professionals trained in the latest ophthalmic technologies |
9 Ireland Ophthalmic Drugs Devices Market - Opportunity Assessment |
9.1 Ireland Ophthalmic Drugs Devices Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Ireland Ophthalmic Drugs Devices Market Opportunity Assessment, By Delivery Method, 2022 & 2032F |
9.3 Ireland Ophthalmic Drugs Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Ireland Ophthalmic Drugs Devices Market Opportunity Assessment, By Application, 2022 & 2032F |
9.5 Ireland Ophthalmic Drugs Devices Market Opportunity Assessment, By Formulation, 2022 & 2032F |
10 Ireland Ophthalmic Drugs Devices Market - Competitive Landscape |
10.1 Ireland Ophthalmic Drugs Devices Market Revenue Share, By Companies, 2025 |
10.2 Ireland Ophthalmic Drugs Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here